Senhwa

Our Pipeline

Developing first-in-class small molecule drugs used in cancer treatments is Senhwa’s corporate mission and currently 2 main compounds CX-5461 and CX-4945 are ongoing phase I/II clinical trials in Australia, Canada, United States, Korea and Taiwan.

View More
Senhwa

Core Value

Senhwa has a strong Management Team with proven track records in developing new drugs and targeted agents. Headquartered in Taiwan, but with a vital operational base in San Diego, California, the Senhwa Team is well positioned to oversee the development of their compounds by collaborating with a diverse range of global investigators and service providers.

View More
Senhwa

Company Video